nhau

Parizvino, kambani iyi yapedza basa rakakodzera rePase II kiriniki yekutsvaga uye kugadzirira kwePase III kiriniki kuyedzwa kweAlbenatide jekiseni. Zvinoenderana nekwokutanga kliniki miedzo yemhedzisiro uye kliniki kubvumidzwa kubvumidzwa zvinodiwa neAlbenatide jekiseni, pamwe chete nemamiriro chaiwo ekambani, kambani inofunga kuti yatove nemamiriro ekutanga chikamu III kiriniki yekuedzwa uye yafunga kutanga chikamu III kiriniki yekuedzwa. .
Albenatide ndeye kirasi 1.1 mushonga wekurapa rudzi rwechipiri chirwere cheshuga. Iyo yakareba-inobata GLP-1 receptor agonist kugadzirira kunogona kuiswa kamwechete pasvondo, iyo inonyatsovandudza kuterera kwemurwere nemishonga.
dgfshgdf (6)
Kambani iyi yakabata chikamu I kliniki yekuedzwa kweAlbenatide jekiseni rekutanga Chipatara cheJilin University, uye kurapwa kwechiitiko cheAlbenatide jekiseni II muzvipatara 28 zvinosanganisira Peking University People's Hospital. Mushure meyedzo yechipiri yechipiri yeAlbenatide Injection yakazadziswa musi waChikumi 7, 2019, kambani iyi yakazoongorora ongororo nehuwandu hwe data yekutsvagisa yakakodzera. Kusvika parizvino, kambani yakapedza chikamu chechipiri kliniki yekutsvagurudza inoenderana neAlbenatide jekiseni. Mhedzisiro yechikamu chechipiri kiriniki kuyedzwa kweiyo Albenatide jekiseni yakaratidza kuti iyo yekupedzisira nzvimbo yechikamu II kliniki muyedzo yakasvikwa.
dgfshgdf (8)


Nguva yekutumira: Jul-01-2020